TokenPost topic

Santen Pharmaceutical

1 TokenPost story is tagged Santen Pharmaceutical. The newest appear first.

Latest Santen Pharmaceutical stories

• Santen Pharmaceutical First-Half Revenue Rises 3.9% to ¥143.289 Billion

  Basic earnings per share was ¥48.05 for the six months ended Sept. 30, 2026. Santen kept its fiscal 2027 revenue and operating profit forecasts unchanged.

  Nov 6, 2026, 8:22 PM EST · Business